Salicylic acid

Description

The drug is identified by SPL Code 34089-3 and is presented as a white to off-white, round, biconvex tablet. The tablet is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. Inactive ingredients consist of lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, “cauliflower-like” surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. It is recommended to soak the wart in warm water for approximately 5 minutes, followed by drying the area completely.

Using the provided applicator, which may be a brush or cotton swab, one drop of the medication should be applied at a time to ensure complete coverage of each wart. It is essential to allow the medication to fully absorb and dry after application.

This procedure may be repeated once or twice daily as necessary, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Application is not recommended on irritated skin or any area that is infected or reddened. Additionally, the product should not be applied to moles, birthmarks, warts with hair growing from them, or warts located on the face or mucous membranes.

Discontinuation of use is advised if discomfort persists. The product is also contraindicated in patients with diabetes or poor blood circulation due to the potential for exacerbating these conditions.

During use, it is essential to avoid contact with the eyes; in the event of contact, the eyes should be flushed with water for 15 minutes. Inhalation of vapors should also be avoided.

Warnings and Precautions

The product is intended for external use only and should be applied exclusively to the affected area. It is imperative to keep the product away from fire and flame to prevent any hazardous incidents.

Caution is advised when using this product. It should not be applied to irritated skin or any area that exhibits signs of infection or redness. Additionally, the product must not be used on moles, birthmarks, or warts that have hair growing from them, nor should it be applied to warts located on the face or mucous membranes.

In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Healthcare professionals should advise patients to discontinue use and consult a physician if discomfort persists. Special attention should be given to individuals with diabetes or poor blood circulation, as they may be at increased risk for complications.

Side Effects

Patients should be aware that the product is intended for external use only and should be applied solely to the affected area. It is crucial to keep the product away from fire and flame to prevent any potential hazards.

In the event that discomfort persists after application, patients are advised to discontinue use. Special caution is warranted for individuals with diabetes or poor blood circulation, as these conditions may increase the risk of adverse reactions. Additionally, the product should be kept out of reach of children. If the product is ingested, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Sual Wart Remover Liquid. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients should be advised against using this product on irritated skin or on any area that is infected or reddened. It is also contraindicated for use on moles, birthmarks, warts with hair growing from them, and warts located on the face or mucous membranes. The product is intended for external use only, and precautions should be taken to keep it out of reach of children. In the event of accidental ingestion, medical assistance should be sought immediately or contact with a Poison Control Center is recommended.

There are no specific studies provided regarding the use of this product during pregnancy; therefore, healthcare professionals should weigh the potential risks and benefits before recommending its use to pregnant patients.

Lactation

There is no specific information regarding the use of SUAL WART REMOVER LIQUID in lactating mothers or lactation considerations. The effects on breastfed infants and the excretion of the drug in human milk have not been established. Healthcare professionals should exercise caution when recommending this product to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the overall clinical context when prescribing this medication to patients with liver problems, as the absence of specific guidance necessitates careful evaluation of potential risks and benefits.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by medical personnel is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to store this product out of the reach of children to prevent accidental ingestion. Patients should be informed that if discomfort persists after use, they should discontinue use immediately.

For patients with diabetes or poor blood circulation, it is essential to instruct them to stop using the product and seek medical advice. In the event of accidental swallowing, patients must be directed to seek medical help or contact a Poison Control Center without delay.

Providers should emphasize the importance of avoiding contact with the eyes. If the product inadvertently gets into the eye, patients should be instructed to flush the eye with water for at least 15 minutes. Additionally, patients should be cautioned against inhaling vapors from the product.

It is important to remind patients to cap the bottle tightly after use and to store the product out of direct sunlight, at room temperature, and away from heat sources to maintain its efficacy.

Storage and Handling

This product is supplied in a container that must be capped tightly after each use to maintain its integrity. It should be stored out of direct sunlight and at room temperature, ensuring it is kept away from heat sources. Additionally, it is essential to keep this product out of the reach of children to ensure safety.

Additional Clinical Information

The medication is administered topically, with the recommended frequency being once or twice daily as needed until the wart is removed, for a maximum duration of 12 weeks. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Sual Wart Remover Liquid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)